Evidence map›Paper›PMID 39554184›Full record

ArticlebioRxiv : the preprint server for biology2025

Counterfactual Diffusion Models for Interpretable Morphology-based Explanations of Artificial Intelligence Models in Pathology.

Laura Žigutytė, Tim Lenz, Tianyu Han, Katherine J Hewitt, Nic G Reitsam, Sebastian Foersch, Zunamys I Carrero, Michaela Unger, Alexander T Pearson, Daniel Truhn and 1 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Laura ŽigutytėElse Kroener Fresenius Center for Digital Health (EKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.ORCID 0009-0000-2447-2959
Tim LenzElse Kroener Fresenius Center for Digital Health (EKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.ORCID 0000-0002-9034-2535
Tianyu HanDepartment of Diagnostic and Interventional Radiology, University Hospital RWTH Aachen, Germany.
Katherine J HewittElse Kroener Fresenius Center for Digital Health (EKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.ORCID 0000-0001-6602-0141
Nic G ReitsamElse Kroener Fresenius Center for Digital Health (EKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.ORCID 0000-0002-0070-3158
Sebastian FoerschInstitute of Pathology, University Medical Center of the Johannes Gutenberg University Mainz, Germany.
Zunamys I CarreroElse Kroener Fresenius Center for Digital Health (EKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.ORCID 0000-0001-8501-1566
Michaela UngerElse Kroener Fresenius Center for Digital Health (EKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.ORCID 0000-0001-5811-0200
Alexander T PearsonSection of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA.
Daniel TruhnDepartment of Diagnostic and Interventional Radiology, University Hospital RWTH Aachen, Germany.
Jakob Nikolas KatherElse Kroener Fresenius Center for Digital Health (EKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.ORCID 0000-0002-3730-5348

Funding

Integration of epidemiology, pathology, immunology and outcomes in colorectal cancerR01CA263318 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI STEPHEN B GRUBER · 2022 to 2026
$3.4M
NCI NIH HHS R01 CA263318
6 · The paper itself

Abstract

Background: Deep learning (DL) can extract predictive and prognostic biomarkers from histopathology whole slide images, but its interpretability remains elusive. Methods: We introduce MoPaDi (Morphing histoPathology Diffusion), a framework for generating counterfactual explanations for histopathology that reveal which morphological features drive deep learning classifier predictions. MoPaDi combines self-supervised diffusion autoencoders with task-specific classifiers to manipulate images and flip predictions by altering visual features. To address weakly supervised scenarios common in pathology, it integrates multiple instance learning. We validate MoPaDi across four tasks: tissue type, cancer subtypes, slide origin, and a biomarker (microsatellite instability) classification. Counterfactuals are evaluated through pathologist studies and quantitative analysis. Results: MoPaDi achieves high image reconstruction quality (MS-SSIM 0.966-0.992) and good classification performance (AUCs 0.76-0.98). In a blinded observer study, two pathologists misclassified between 26.7% and 63.3% of synthetic images as real across all tasks, indicating that MoPaDi-generated images often exhibit high perceptual realism. Furthermore, counterfactual images revealed interpretable, pathology-consistent morphological changes recognizable by experts. Conclusion: MoPaDi is a practical and extensible framework for counterfactual explanations generation in computational pathology. It enables interpretable, model-specific insight into what morphological changes drive classification outcomes, improving interpretability in clinical deep learning models.

Identifiers

PMID39554184
PMCPMC11565818

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.